COMP <GO>
WVE vs GYRE // RSI-14 & 200D SMA MOMENTUM
Wave Life Sciences Inc. (NASDAQ) VS. Gyre Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: WVE 2
— GYRE 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: WVE
LAST: $3.63 (-0.28%) • MKT CAP: $715.9M
rsi-technicals
49.1
LAST: $6.41 (-9.59%) • MKT CAP: $714.8M
rsi-technicals
29.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WVE VS. GYRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WVE | GYRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 95.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.40% | -60.40 | GYRE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 53.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -0.03% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 9.90% | -69.90 | GYRE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 8.50% | -68.50 | GYRE | /net-margins <GO> |
| Revenue Growth (YoY) | -60.50% | 10.20% | -70.70 | GYRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.85 | 14.33 | -13.48 | GYRE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | GYRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 49.1 | 29.5 | +19.56 | WVE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 67.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $715.9M | $714.8M | $1.2M | WVE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WVE REV | GYRE REV | WVE GROSS % | GYRE GROSS % | WVE FCF | GYRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $42.7M | $116.6M | — | 95.4% | -$188.2M | -$180.0K |
| FY 2024 | $108.3M | $105.8M | — | 96.3% | -$152.0M | -$6.0M |
| FY 2023 | $113.3M | $113.5M | — | — | -$19.4M | $25.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WVE // BETA —
GYRE // BETA —